Sunil Dhawan, MD
Clinical Assistant Professor of DermatologyStanford University
Sunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed care. Dr. Dhawan also runs the clinical trial division in his group practice, East Bay Dermatology Medical Group, where he has performed over 25 trials for all the major pharmaceutical companies. He has consulted for companies such as Allergan, Obagi, Connetics, Galderma, Astellas, Medicis, Amgen, and Stiefel. Dr. Dhawan is on the board of the local physician run IPA, as well as the utilization committee of the largest IPA in Silicon Valley. (This is me - Update Profile)
| 1992 - present | Clinical Assistant Professor of Dermatology Stanford University |
|---|---|
| 1990 - present | Dermatologist East Bay Dermatology Medical Group Inc |
GLG Study Groups with Sunil Dhawan, MD(?)
| Study Group Name | Members |
|---|---|
| Cosmetic Dermatologists (US) | 254 |
| Dermatologists (US) | 571 |
| Hair Restoration Dermatologists (US) | 258 |
| Juvederm Users: Cosmetic Dermatologists (US) | 113 |
GLG NewsSM
Analyses by Sunil Dhawan, MD(?)
This article is important in that it describes a worrying trend for branded pharmaceutical companies. As copays for branded products go up and the patients economic status worsens, the use of these drugs will fall. This may be especially true for medications in dermatology, where the perceived...
This article is important in that it confirms a commonly used method in clinical dermatology practice. Namely that of using Protopic for longer term maintenance to prevent flares, and to act as a topical steroid sparing agent. This has been done since the introduction of Protopic, and among dermatologists...
This article is important because it describes a growing concern that is not well known to the investment community or the public. Due to increased pressure from the generic companies, the FDA, and the public many companies are finding new uses for older medications. This is very true in dermatology...
This article is important because it outlines the rationale and benefits of the new collagen based filler from Ortho-Neutrogena/ Johnson and Johnson. This filler appears to last at least 6 months, and does not require pre testing as other collagen based fillers have needed in the past. The fact that...
GLG InstituteSM Seminars with Sunil Dhawan, MD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Sunil Dhawan, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

